Search Share Prices
GSK Headlines - Jefferies Financial Group Analysts Give GlaxoSmithKline plc (GSK.L) (LON:GSK) a GBX 1,950 Price Target
GlaxoSmithKline plc (GSK.L) (LON:GSK) received a GBX 1,950 ($25.48) price target from equities researchers at Jefferies Financial Group in a report issued on Wednesday, Borsen Zeitung reports. The ...
Why has the GSK share price failed to take part in the FTSE 100 index’s recovery?
Could investor sentiment towards the GSK share price (LON: GSK) (GSK.L) remain weak after its underperformance versus the FTSE 100 index (INDEXFTSE: UKX) in the past 3 months?
Injectable Drugs for Type-2 Diabetes Market with (Covid-19) Impact Analysis: Competitive Scenario and Developments in the Market, 2028
Research Nester published a report titled "Injectable Drugs for Type-2 Diabetes Market: Global Demand Analysis ...
GlaxoSmithKline plc (GSK.L) (LON:GSK) Stock Rating Reaffirmed by The Goldman Sachs Group
The Goldman Sachs Group reaffirmed their buy rating on shares of GlaxoSmithKline plc (GSK.L) (LON:GSK) in a report published on Monday, AR Network reports. The Goldman Sachs Group currently has a GBX ...
GlaxoSmithKline-owned ViiV Healthcare receives green light for long-acting HIV treatment
ViiV Healthcare, the specialist HIV company majority-owned by GlaxoSmithKline PLC , has received marketing approval for a long-acting therapy for the condition. ViiV’s Vocabria ...